3D62

Development of Broad-Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro

3D62 の概要

• エントリーDOI: 10.2210/pdb3d62/pdb
• 分子名称: 3C-like proteinase, benzyl (2-oxopropyl)carbamate (3 entities in total)
• 機能のキーワード: main protease 3clpro, sars, inhibitor, 95990, atp-binding, endonuclease, exonuclease, helicase, hydrolase, membrane, metal-binding, nuclease, nucleotide-binding, nucleotidyltransferase, rna replication, rna-binding, rna-directed rna polymerase, thiol protease, transferase, transmembrane, zinc-finger
• 由来する生物種: SARS coronavirus
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 33407.15

構造登録者

Bacha, U.,Barrila, J.,Gabelli, S.B.,Kiso, Y.,Amzel, L.M.,Freire, E. (登録日: 2008-05-18, 公開日: 2008-07-01, 最終更新日: 2024-10-30)

主引用文献

Bacha, U.,Barrila, J.,Gabelli, S.B.,Kiso, Y.,Mario Amzel, L.,Freire, E.
Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro).
Chem.Biol.Drug Des., 72:34-49, 2008

PubMed Abstract: Coronaviruses comprise a large group of RNA viruses with diverse host specificity. The emergence of highly pathogenic strains like the SARS coronavirus (SARS-CoV), and the discovery of two new coronaviruses, NL-63 and HKU1, corroborates the high rate of mutation and recombination that have enabled them to cross species barriers and infect novel hosts. For that reason, the development of broad-spectrum antivirals that are effective against several members of this family is highly desirable. This goal can be accomplished by designing inhibitors against a target, such as the main protease 3CL(pro) (M(pro)), which is highly conserved among all coronaviruses. Here 3CL(pro) derived from the SARS-CoV was used as the primary target to identify a new class of inhibitors containing a halomethyl ketone warhead. The compounds are highly potent against SARS 3CL(pro) with K(i)'s as low as 300 nM. The crystal structure of the complex of one of the compounds with 3CL(pro) indicates that this inhibitor forms a thioether linkage between the halomethyl carbon of the warhead and the catalytic Cys 145. Furthermore, Structure Activity Relationship (SAR) studies of these compounds have led to the identification of a pharmacophore that accurately defines the essential molecular features required for the high affinity.

PubMed: 18611220
DOI: 10.1111/j.1747-0285.2008.00679.x

実験手法

X-RAY DIFFRACTION (2.7 Å)